DCF — KAWEAH DELTA MEDICAL CENTER
Enterprise Value: $-578.1M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-578.1M
Enterprise Value
$-193.4M
PV of Cash Flows
$-384.7M
PV of Terminal Value
$-619.6M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $673.3M | $-30.3M | -5.0% | $-58.8M | $-53.5M |
| Year 2 | $693.5M | $-24.3M | -4.0% | $-53.6M | $-44.3M |
| Year 3 | $714.3M | $-17.9M | -3.0% | $-48.1M | $-36.1M |
| Year 4 | $735.7M | $-14.7M | -2.0% | $-45.9M | $-31.3M |
| Year 5 | $757.8M | $-13.3M | -2.0% | $-45.3M | $-28.2M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-578.1M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$653.7M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.05000000007649031
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5